| Info. | Vol.17 - No.4 (2023.12.20) |
|---|---|
| Title | Inflammatory Bowel Disease: Pathophysiology, Treatment, and Disease Modeling |
| Authors | Jiryeon Jang1, Sehoon Jeong2,3,4*
Jiryeon Jang: First author. *Sehoon Jeong jeongsh422@gmail.com ; jeongsh@inje.ac.kr |
| Institutions | 1 Lehrstühl Fur Strömungsmechanik Erlangen (LSTME), Busan 46742, Republic of Korea
2Department of Healthcare Information Technology, Inje University, 197 Inje-Ro, Gimhae, 50834, Republic of Korea 3Paik Institute for Clinical Research, Inje University, Busan 47392, Republic of Korea 4 Institute for Digital Antiaging and Healthcare, Inje University, Gimhae 50834, Republic of Korea |
| Abstract | Inflammatory Bowel Disease (IBD) affects a substantial global population and is characterized by chronic inflammation primarily in the gastrointestinal tract. The pathophysiology of IBD is intricate and involves a combination of genetic, envi-ronmental, and immune-related factors. This article aims to discuss the current understanding of IBD pathophysiology, focusing on the roles of genetics, environmental triggers, and the immune system in disease development and progression. In addition, the review covers the existing treatment options for IBD, including medical and surgical interventions while addressing the challenges associated with managing this chronic condition. Furthermore, the article explores the utility of disease modeling techniques, such as animal models, in vitro organoid models, and microfluidic organ-on-a-chip devices, for studying IBD pathophysiology and evaluating potential therapeutic interventions. It is important to note that conventional two-dimensional (2D) cell cultures are limited in capturing essential physical and biochemical cues, despite displaying lineage-specific differences. The translation of data from animal models to human physiology in major systems undermines the reliability of the generated data. To address these limitations, one noteworthy solution is the utilization of microfl uidic- based organ-on-a-chip devices, which can effectively mimic organ functionality. These devices are developed based on principles of microfluidics, materials science, and cell biology. Overall, this comprehensive review provides insights into the pathophysiology of IBD, current treatment options, and disease modeling approaches, including emerging technologies, such as organoids and organ-on-a-chip. These advancements offer promising avenues for enhancing our understanding of IBD and developing more efficient therapies for this debilitating condition. |
| Keyword | Inflammatory Bowel Disease (IBD) · Chron’s disease (CD) · Ulcerative colitis (UC) · Organ-on-a-chip · Organoids |
| PDF File |
 # 2010년도 발행분 부터는 Springer 의 BioChip Journal 페이지에서 전문을 열람하실 수 있습니다.
# 학회회원 로그인 후 [ Springer BioChip Journal 열람하기 ] 버튼을 클릭하시면 새창으로 열립니다. |
